Levetiracetam Tablet
Product Images NDC 70518-4301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-4301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text provides information about LevETIRAcetam, a prescription medication in the form of tablets with a strength of 500 mg. The medication is manufactured by Tris Pharma, Inc. and should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). The package contains 30 tablets and the user is instructed to see the Package Insert for directions on use. It is important to keep this medication, along with all other medications, out of the reach of children.*
FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

FDA Label Image

Figure 1 (Levetiracetam Tablets 2)

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

Figure2 (Levetiracetam Tablets 3)
This text shows data related to the percentage of patients on a placebo and a specific medication (Levetiracetam 2000 mg daily). The percentages mentioned are 63% and 208%. The text also includes the number of patients in each group (H=111 for placebo and N=105 for Levetiracetam). These details seem to be part of a clinical trial or study.*
FDA Label Image

Figure3 (Levetiracetam Tablets 4)

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

Figure4 (Levetiracetam Tablets 5)
This text provides data on percentages and sample sizes for two groups, Placebo (N=97) and Levetiracetam (N=101). The numbers suggest values ranging from 0% to 19.6%. Further information such as the context of the study or the specific variables being measured would be needed for a comprehensive evaluation.*
FDA Label Image

Figure5 (Levetiracetam Tablets 6)

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.